Ji Ruan. (2021). MET Inhibitor is Expected to Overcome MET Amplification-Induced Immunotherapy Resistance in Non-Small Cell Lung Cancer. Elsevier.
Chicago Style (17th ed.) CitationJi Ruan. MET Inhibitor Is Expected to Overcome MET Amplification-Induced Immunotherapy Resistance in Non-Small Cell Lung Cancer. Elsevier, 2021.
MLA (9th ed.) CitationJi Ruan. MET Inhibitor Is Expected to Overcome MET Amplification-Induced Immunotherapy Resistance in Non-Small Cell Lung Cancer. Elsevier, 2021.
Warning: These citations may not always be 100% accurate.